Biotricity amends ATM offering to raise up to $2.68M in common stock

BIOTRICITY INC.

Amendment to March 2022 ATM agreement with H.C. Wainwright for up to $2,684,644 of common stock.
New registration statement on Form S-3 (File 333-279226) effective May 15, 2024, governs the offering.
Wainwright continues as sales agent; settlement cycle shortened to T+1 per updated rule.
Company adds representation that it is not an investment company under the 1940 Act.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.